Acetylcholinesterase inhibitors

Intervention

1 paper3 findings

  • 1 lab in 1 country
  • Funders: Novo Nordisk and 1 more
  • 3 of 3 findings with company ties
  • Humans1

Associations

3

Mortality

upin humans1

1 study
  1. Acetylcholinesterase inhibitors are associated with mortality in humans (53.3% vs. 21.7%).

    Humanspost-initiation5 years

    A comprehensive German claims data analysis of care pathways, risk factors and comorbidities among acetylcholinesterase inhibitor initiators in Alzheimer's disease

    Scientific reports31 Aug 2026

Mobility disorders

upin humans1+55%

1 study
  1. Acetylcholinesterase inhibitors are associated with mobility disorders in humans (+ 55%).

    Humanspre-initiation period8 years

    A comprehensive German claims data analysis of care pathways, risk factors and comorbidities among acetylcholinesterase inhibitor initiators in Alzheimer's disease

    Scientific reports31 Aug 2026

More on Mobility disorders

Modifiable risk factors

upin humans1

1 study
  1. Acetylcholinesterase inhibitors are associated with modifiable risk factors in humans (81.9% vs. 76.2%).

    Humanseight years pre-initiation

    A comprehensive German claims data analysis of care pathways, risk factors and comorbidities among acetylcholinesterase inhibitor initiators in Alzheimer's disease

    Scientific reports31 Aug 2026

Latest

Nov 2025: 0Dec 2025: 0Jan 2026: 0Feb 2026: 0Mar 2026: 0Apr 2026: 0May 2026: 0Jun 2026: 0Jul 2026: 0Aug 2026: 1Sep 2026: 0Oct 2026: 01 in 12 months